Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Escande, D
   Inhibition of repolarizing ionic currents by drugs
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   D. Escande, "Inhibition of repolarizing ionic currents by drugs", EUR H J SUP, 3(K), 2001, pp. K17-K22
2. Lacerda, AE; Kramer, J; Shen, KZ; Thomas, D; Brown, AM
   Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   A.E. Lacerda et al., "Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs", EUR H J SUP, 3(K), 2001, pp. K23-K30
3. Schulze-Bahr, E; Haverkamp, W; Eckardt, L; Kirchhof, P; Wedekind, H; Breithardt, G
   Genetic aspects in acquired long QT syndrome - a piece in the puzzle
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   E. Schulze-Bahr et al., "Genetic aspects in acquired long QT syndrome - a piece in the puzzle", EUR H J SUP, 3(K), 2001, pp. K48-K52
4. Cavero, I; Crumb, W
   Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugs
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   I. Cavero e W. Crumb, "Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugs", EUR H J SUP, 3(K), 2001, pp. K53-K63
5. Iwasa, H; Kurabayashi, M; Nagai, R; Nakamura, Y; Tanaka, T
   Genetic variations in five genes involved in the excitement of cardiomyocytes
   JOURNAL OF HUMAN GENETICS
   
   H. Iwasa et al., "Genetic variations in five genes involved in the excitement of cardiomyocytes", J HUM GENET, 46(9), 2001, pp. 549-552
6. Iwasa, H; Kurabayashi, M; Nagai, R; Nakamura, Y; Tanaka, T
   Multiple single-nucleotide polymorphisms (SNPs) in the Japanese populationin six candidate genes for long QT syndrome
   JOURNAL OF HUMAN GENETICS
   
   H. Iwasa et al., "Multiple single-nucleotide polymorphisms (SNPs) in the Japanese populationin six candidate genes for long QT syndrome", J HUM GENET, 46(3), 2001, pp. 158-162
7. Itoh, T; Kikuchi, K; Odagawa, Y; Takata, S; Yano, K; Okada, S; Haneda, N; Ogawa, S; Nakano, O; Kawahara, Y; Kasai, H; Nakayama, T; Fukutomi, T; Sakurada, H; Shimizu, A; Yazaki, Y; Nagai, R; Nakamura, Y; Tanaka, T
   Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome
   JOURNAL OF HUMAN GENETICS
   
   T. Itoh et al., "Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome", J HUM GENET, 46(1), 2001, pp. 38-40
8. Netzer, R; Ebneth, A; Bischoff, U; Pongs, O
   Screening lead compounds for QT interval prolongation
   DRUG DISCOVERY TODAY
   
   R. Netzer et al., "Screening lead compounds for QT interval prolongation", DRUG DISC T, 6(2), 2001, pp. 78-84
9. Paavonen, KJ; Swan, H; Piippo, K; Hokkanen, L; Laitinen, P; Viitasalo, M; Toivonen, L; Kontula, K
   Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome
   HEART
   
   K.J. Paavonen et al., "Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome", HEART, 86(1), 2001, pp. 39-44
10. Priori, SG; Bloise, R; Crotti, L
    The long QT syndrome
    EUROPACE
    
    S.G. Priori et al., "The long QT syndrome", EUROPACE, 3(1), 2001, pp. 16-27
11. Pond, AL; Nerbonne, JM
    ERG proteins and functional cardiac I-Kr channels in rat, mouse, and humanheart
    TRENDS IN CARDIOVASCULAR MEDICINE
    
    A.L. Pond e J.M. Nerbonne, "ERG proteins and functional cardiac I-Kr channels in rat, mouse, and humanheart", TREND CARD, 11(7), 2001, pp. 286-294
12. Kubota, T; Horie, M; Takano, M; Yoshida, H; Takenaka, K; Watanabe, E; Tsuchiya, T; Otani, H; Sasayama, S
    Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    T. Kubota et al., "Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias", J CARD ELEC, 12(11), 2001, pp. 1223-1229
13. Schulze-Bahr, E; Schwarz, M; Hoffmann, S; Wedekind, H; Funke, H; Haverkamp, W; Breithardt, G; Pongs, O; Isbrandt, D
    A novel long-QT 5 gene mutation in the C-terminus (V1091) is associated with a mild phenotype
    JOURNAL OF MOLECULAR MEDICINE-JMM
    
    E. Schulze-Bahr et al., "A novel long-QT 5 gene mutation in the C-terminus (V1091) is associated with a mild phenotype", J MOL MED-J, 79(9), 2001, pp. 504-509
14. Lupoglazoff, JM; Denjoy, I; Guicheney, P; Casasoprana, A; Coumel, P
    Long QT syndrome.
    ARCHIVES DE PEDIATRIE
    
    J.M. Lupoglazoff et al., "Long QT syndrome.", ARCH PED, 8(5), 2001, pp. 525-534
15. Tanabe, Y; Inagaki, M; Kurita, T; Nagaya, N; Taguchi, A; Suyama, K; Aihara, N; Kamakura, S; Sunagawa, K; Nakamura, K; Ohe, T; Towbin, JA; Priori, SG; Shimizu, W
    Sympathetic stimulation produces a greater increase in both transmural andspatial dispersion of repolarization in LQT1 than LQT2 forms of congenitallong QT syndrome
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    Y. Tanabe et al., "Sympathetic stimulation produces a greater increase in both transmural andspatial dispersion of repolarization in LQT1 than LQT2 forms of congenitallong QT syndrome", J AM COL C, 37(3), 2001, pp. 911-919
16. Piippo, K; Swan, H; Pasternack, M; Chapman, H; Paavonen, K; Viitasalo, M; Toivonen, L; Kontula, K
    A founder mutation of the potassium channel KCNQ1 in long QT syndrome - Implications for estimation of disease prevalence and molecular diagnostics
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    K. Piippo et al., "A founder mutation of the potassium channel KCNQ1 in long QT syndrome - Implications for estimation of disease prevalence and molecular diagnostics", J AM COL C, 37(2), 2001, pp. 562-568
17. Gerlach, U
    I-Ks channel blockers: potential antiarrhythmic agents
    DRUGS OF THE FUTURE
    
    U. Gerlach, "I-Ks channel blockers: potential antiarrhythmic agents", DRUG FUTURE, 26(5), 2001, pp. 473-484
18. Chiang, HT; Wu, SN
    On the mechanism of selective action of probucol on the inwardly rectifying potassium current in GH(3) lactotrophs
    DRUG DEVELOPMENT RESEARCH
    
    H.T. Chiang e S.N. Wu, "On the mechanism of selective action of probucol on the inwardly rectifying potassium current in GH(3) lactotrophs", DRUG DEV R, 54(1), 2001, pp. 1-11
19. Tie, H; Walker, BD; Singleton, CB; Bursill, JA; Wyse, KR; Campbell, TJ; Valenzuela, SM; Breit, SN
    Clozapine and sudden death
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    H. Tie et al., "Clozapine and sudden death", J CL PSYCH, 21(6), 2001, pp. 630-632
20. Johnson, JP; Balser, JR; Bennett, PB
    A novel extracellular calcium sensing mechanism in voltage-gated potassiumion channels
    JOURNAL OF NEUROSCIENCE
    
    J.P. Johnson et al., "A novel extracellular calcium sensing mechanism in voltage-gated potassiumion channels", J NEUROSC, 21(12), 2001, pp. 4143-4153
21. Ackerman, MJ; Tester, DJ; Driscoll, DJ
    Molecular autopsy of sudden unexplained death in the young
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY
    
    M.J. Ackerman et al., "Molecular autopsy of sudden unexplained death in the young", AM J FOREN, 22(2), 2001, pp. 105-111
22. Taglialatela, M; Pannaccione, A; Cataldi, M; Castaldo, P; Secondo, A; Iossa, S; Di Renzo, GF; Annunziato, L
    "Janus face" of nitric oxide action on plasma membrane and intracellular ionic channels
    ARCHIVES OF GERONTOLOGY AND GERIATRICS
    
    M. Taglialatela et al., ""Janus face" of nitric oxide action on plasma membrane and intracellular ionic channels", ARCH GER G, 2001, pp. 379-394
23. Yoshida, H; Horie, M; Otani, H; Kawashima, T; Onishi, Y; Sasayama, S
    Bradycardia-induced long QT syndrome caused by a de novo missense mutationin the S2-S3 inner loop of HERG
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    H. Yoshida et al., "Bradycardia-induced long QT syndrome caused by a de novo missense mutationin the S2-S3 inner loop of HERG", AM J MED G, 98(4), 2001, pp. 348-352
24. Malik, M; Camm, AJ
    Evaluation of drug-induced QT interval prolongation - Implications for drug approval and labelling
    DRUG SAFETY
    
    M. Malik e A.J. Camm, "Evaluation of drug-induced QT interval prolongation - Implications for drug approval and labelling", DRUG SAFETY, 24(5), 2001, pp. 323-351
25. Towbin, JA; Wang, ZQ; Li, H
    Genotype and severity of long QT syndrome
    DRUG METABOLISM AND DISPOSITION
    
    J.A. Towbin et al., "Genotype and severity of long QT syndrome", DRUG META D, 29(4), 2001, pp. 574-579
26. Ohyama, H; Kajita, H; Omori, K; Takumi, T; Hiramoto, N; Iwasaka, T; Matsuda, H
    Inhibition of cardiac delayed rectifier K+ currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N inneonatal mouse hearts
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    H. Ohyama et al., "Inhibition of cardiac delayed rectifier K+ currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N inneonatal mouse hearts", PFLUG ARCH, 442(3), 2001, pp. 329-335
27. Zehelein, J; Zhang, W; Koenen, M; Graf, M; Heinemann, SH; Katus, HA
    Molecular cloning and expression of cERG, the ether a go-go-related gene from canine myocardium
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    J. Zehelein et al., "Molecular cloning and expression of cERG, the ether a go-go-related gene from canine myocardium", PFLUG ARCH, 442(2), 2001, pp. 188-191
28. Wimmers, S; Wulfsen, I; Bauer, CK; Schwarz, JR
    Erg1, erg2 and erg3 K channel subunits are able to form heteromultimers
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    S. Wimmers et al., "Erg1, erg2 and erg3 K channel subunits are able to form heteromultimers", PFLUG ARCH, 441(4), 2001, pp. 450-455
29. Meves, H
    Slowing of ERG current deactivation in NG108-15 cells by the histidine-specific reagent diethylpyrocarbonate
    NEUROPHARMACOLOGY
    
    H. Meves, "Slowing of ERG current deactivation in NG108-15 cells by the histidine-specific reagent diethylpyrocarbonate", NEUROPHARM, 41(2), 2001, pp. 220-228
30. Chen, J; Mitcheson, JS; Tristani-Firouzi, M; Lin, M; Sanguinetti, MC
    The S4-S5 linker couples voltage sensing and activation of pacemaker channels
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J. Chen et al., "The S4-S5 linker couples voltage sensing and activation of pacemaker channels", P NAS US, 98(20), 2001, pp. 11277-11282
31. Ficker, E; Jarolimek, W; Brown, AM
    Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K+ channels
    MOLECULAR PHARMACOLOGY
    
    E. Ficker et al., "Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K+ channels", MOLEC PHARM, 60(6), 2001, pp. 1343-1348
32. O'Leary, ME
    Inhibition of human ether-a-go-go potassium channels by cocaine
    MOLECULAR PHARMACOLOGY
    
    M.E. O'Leary, "Inhibition of human ether-a-go-go potassium channels by cocaine", MOLEC PHARM, 59(2), 2001, pp. 269-277
33. Clayton, RH; Bailey, A; Biktashev, VN; Holden, AV
    Re-entrant cardiac arrhythmias in computational models of long QT myocardium
    JOURNAL OF THEORETICAL BIOLOGY
    
    R.H. Clayton et al., "Re-entrant cardiac arrhythmias in computational models of long QT myocardium", J THEOR BIO, 208(2), 2001, pp. 215-225
34. Potet, F; Bouyssou, T; Escande, D; Baro, I
    Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K+ channel
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    F. Potet et al., "Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K+ channel", J PHARM EXP, 299(3), 2001, pp. 1007-1012
35. Thomas, D; Wendt-Nordahl, G; Rockl, K; Ficker, E; Brown, AM; Kiehn, J
    High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    D. Thomas et al., "High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872", J PHARM EXP, 297(2), 2001, pp. 753-761
36. Roden, DM
    Defective ion channel function in the long QT syndrome: Multiple unexpected mechanisms
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    
    D.M. Roden, "Defective ion channel function in the long QT syndrome: Multiple unexpected mechanisms", J MOL CEL C, 33(2), 2001, pp. 185-187
37. Yamashita, F; Horie, M; Kubota, T; Yoshida, H; Yumoto, Y; Kobori, A; Ninomiya, T; Kono, Y; Haruna, T; Tsuji, K; Washizuka, T; Takano, M; Otani, H; Sasayama, S; Aizawa, Y
    Characterization and subcellular localization of KCNQ1 with a heterozygousmutation in the C terminus
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    
    F. Yamashita et al., "Characterization and subcellular localization of KCNQ1 with a heterozygousmutation in the C terminus", J MOL CEL C, 33(2), 2001, pp. 197-207
38. Rowley, M; Hallett, DJ; Goodacre, S; Moyes, C; Crawforth, J; Sparey, TJ; Patel, S; Marwood, R; Patel, S; Thomas, S; Hitzel, L; O'Connor, D; Szeto, N; Castro, JL; Hutson, PH; MacLeod, AM
    3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist
    JOURNAL OF MEDICINAL CHEMISTRY
    
    M. Rowley et al., "3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist", J MED CHEM, 44(10), 2001, pp. 1603-1614
39. Ishii, K; Kondo, K; Takahashi, M; Kimura, M; Endoh, M
    An amino acid residue whose change by mutation affects drug binding to theHERG channel
    FEBS LETTERS
    
    K. Ishii et al., "An amino acid residue whose change by mutation affects drug binding to theHERG channel", FEBS LETTER, 506(3), 2001, pp. 191-195
40. Finlayson, K; Turnbull, L; January, CT; Sharkey, J; Kelly, JS
    [H-3]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    K. Finlayson et al., "[H-3]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen", EUR J PHARM, 430(1), 2001, pp. 147-148
41. Dumotier, BM; Bastide, M; Adamantidis, MM
    "Use-dependent" effects of cisapride on postrest action potentials in rabbit ventricular myocardium
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    B.M. Dumotier et al., ""Use-dependent" effects of cisapride on postrest action potentials in rabbit ventricular myocardium", EUR J PHARM, 422(1-3), 2001, pp. 137-148
42. Finlayson, K; Pennington, AJ; Kelly, JS
    [H-3]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    K. Finlayson et al., "[H-3]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?", EUR J PHARM, 412(3), 2001, pp. 203-212
43. Larsen, LA; Andersen, PS; Kanters, J; Svendsen, IH; Jacobsen, JR; Vuust, J; Wettrell, G; Tranebjaerg, L; Bathen, J; Christiansen, M
    Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRPI ion channel: Implications for acquired and congenital long Q-T syndrome
    CLINICAL CHEMISTRY
    
    L.A. Larsen et al., "Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRPI ion channel: Implications for acquired and congenital long Q-T syndrome", CLIN CHEM, 47(8), 2001, pp. 1390-1395
44. Kimbrough, J; Moss, AJ; Zareba, W; Robinson, JL; Hall, J; Benhorin, J; Locati, EH; Medina, A; Napolitano, C; Priori, S; Schwartz, PJ; Timothy, K; Towbin, JA; Vincent, GM; Zhang, L
    Clinical implications for affected parents and siblings of probands with long-QT syndrome
    CIRCULATION
    
    J. Kimbrough et al., "Clinical implications for affected parents and siblings of probands with long-QT syndrome", CIRCULATION, 104(5), 2001, pp. 557-562
45. Franco, D; Demolombe, S; Kupershmidt, S; Dumaine, R; Dominguez, JN; Roden, D; Antzelevitch, C; Escande, D; Moorman, AFM
    Divergent expression of delayed rectifier K+ channel subunits during mouseheart development
    CARDIOVASCULAR RESEARCH
    
    D. Franco et al., "Divergent expression of delayed rectifier K+ channel subunits during mouseheart development", CARDIO RES, 52(1), 2001, pp. 65-75
46. Huang, LQ; Bitner-Glindzicz, M; Tranebjaerg, L; Tinker, A
    A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome
    CARDIOVASCULAR RESEARCH
    
    L.Q. Huang et al., "A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome", CARDIO RES, 51(4), 2001, pp. 670-680
47. Lande, G; Demolombe, S; Bammert, A; Moorman, A; Charpentier, F; Escande, D
    Transgenic mice overexpressing human KvLQT1 dominant-negative isoform PartII: Pharmacological profile
    CARDIOVASCULAR RESEARCH
    
    G. Lande et al., "Transgenic mice overexpressing human KvLQT1 dominant-negative isoform PartII: Pharmacological profile", CARDIO RES, 50(2), 2001, pp. 328-334
48. Taglialatela, M; Secondo, A; Fresi, A; Rosati, B; Pannaccione, A; Castaldo, P; Giorgio, G; Wanke, E; Annunziato, L
    Inhibition of depolarization-induced [H-3]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H-1 receptor antagonists through blockade of store-operated Ca2+ channels (SOCs)
    BIOCHEMICAL PHARMACOLOGY
    
    M. Taglialatela et al., "Inhibition of depolarization-induced [H-3]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H-1 receptor antagonists through blockade of store-operated Ca2+ channels (SOCs)", BIOCH PHARM, 62(9), 2001, pp. 1229-1238
49. Shuba, YM; Degtiar, VE; Osipenko, VN; Naidenov, VG; Woosley, RL
    Testosterone-mediated modulation of HERG blockade by proarrhythmic agents
    BIOCHEMICAL PHARMACOLOGY
    
    Y.M. Shuba et al., "Testosterone-mediated modulation of HERG blockade by proarrhythmic agents", BIOCH PHARM, 62(1), 2001, pp. 41-49
50. Fontana, L; D'Amico, M; Crociani, O; Biagiotti, T; Solazzo, M; Rosati, B; Arcangeli, A; Wanke, E; Olivotto, M
    Long-term modulation of HERG channel gating in hypoxia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    L. Fontana et al., "Long-term modulation of HERG channel gating in hypoxia", BIOC BIOP R, 286(5), 2001, pp. 857-862
51. Kang, JS; Chen, XL; Rampe, D
    The antipsychotic drugs sertindole and pimozide block erg3, a human brain K+ channel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    J.S. Kang et al., "The antipsychotic drugs sertindole and pimozide block erg3, a human brain K+ channel", BIOC BIOP R, 286(3), 2001, pp. 499-504
52. Paul, AA; Witchel, HJ; Hancox, JC
    Inhibition of HERG potassium channel current by the Class 1a antiarrhythmic agent disopyramide
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    A.A. Paul et al., "Inhibition of HERG potassium channel current by the Class 1a antiarrhythmic agent disopyramide", BIOC BIOP R, 280(5), 2001, pp. 1243-1250
53. Piippo, K; Holmstrom, S; Swan, H; Viitasalo, M; Raatikka, M; Toivonen, L; Kontula, K
    Effect of the antimalarial drug Halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A
    AMERICAN JOURNAL OF CARDIOLOGY
    
    K. Piippo et al., "Effect of the antimalarial drug Halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A", AM J CARD, 87(7), 2001, pp. 909
54. Iwasa, H; Itoh, T; Nagai, R; Nakamura, Y; Tanaka, T
    Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population
    JOURNAL OF HUMAN GENETICS
    
    H. Iwasa et al., "Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population", J HUM GENET, 45(3), 2000, pp. 182-183
55. Berul, CI
    Neonatal long QT syndrome and sudden cardiac death
    PROGRESS IN PEDIATRIC CARDIOLOGY
    
    C.I. Berul, "Neonatal long QT syndrome and sudden cardiac death", PROG PEDI C, 11(1), 2000, pp. 47-54
56. Gralinski, MR
    The assessment of potential for QT interval prolongation with new pharmaceuticals Impact on drug development
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    
    M.R. Gralinski, "The assessment of potential for QT interval prolongation with new pharmaceuticals Impact on drug development", J PHARM TOX, 43(2), 2000, pp. 91-99
57. Kubota, T; Shimizu, W; Kamakura, S; Horie, M
    Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    T. Kubota et al., "Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1", J CARD ELEC, 11(9), 2000, pp. 1048-1054
58. Napolitano, C; Schwartz, PJ; Brown, AM; Ronchetti, E; Bianchi, L; Pinnavaia, A; Acquaro, G; Priori, SG
    Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    C. Napolitano et al., "Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias", J CARD ELEC, 11(6), 2000, pp. 691-696
59. January, CT; Gong, QM; Zhou, ZF
    Long QT syndrome: Cellular basis and arrhythmia mechanism in LQT2
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    C.T. January et al., "Long QT syndrome: Cellular basis and arrhythmia mechanism in LQT2", J CARD ELEC, 11(12), 2000, pp. 1413-1418
60. Ludwig, J; Weseloh, R; Karschin, C; Liu, Q; Netzer, R; Engeland, B; Stansfeld, C; Pongs, O
    Cloning and functional expression of rat eag2, a new member of the ether-a-go-go family of potassium channels and comparison of its distribution withthat of eag1
    MOLECULAR AND CELLULAR NEUROSCIENCE
    
    J. Ludwig et al., "Cloning and functional expression of rat eag2, a new member of the ether-a-go-go family of potassium channels and comparison of its distribution withthat of eag1", MOL CELL NE, 16(1), 2000, pp. 59-70
61. Varshney, A; Mathew, MK
    Cytoplasmic residues influence the voltage-dependence of the gating of human K+ channels
    NEUROREPORT
    
    A. Varshney e M.K. Mathew, "Cytoplasmic residues influence the voltage-dependence of the gating of human K+ channels", NEUROREPORT, 11(13), 2000, pp. 2913-2917
62. Crociani, O; Cherubini, A; Piccini, E; Polvani, S; Costa, L; Fontana, L; Hofmann, G; Rosati, B; Wanke, E; Olivotto, M; Arcangeli, A
    erg gene(s) expression during development of the nervous and muscular system of quail embryos
    MECHANISMS OF DEVELOPMENT
    
    O. Crociani et al., "erg gene(s) expression during development of the nervous and muscular system of quail embryos", MECH DEVEL, 95(1-2), 2000, pp. 239-243
63. Duff, HJ
    Molecular diagnosis and treatment of cardiovascular diseases
    CANADIAN JOURNAL OF CARDIOLOGY
    
    H.J. Duff, "Molecular diagnosis and treatment of cardiovascular diseases", CAN J CARD, 16(3), 2000, pp. 304-306
64. Bianchi, L; Priori, SG; Napolitano, C; Surewicz, KA; Dennis, AT; Memmi, M; Schwartz, PJ; Brown, AM
    Mechanisms of I-Ks suppression in LQT1 mutants
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    
    L. Bianchi et al., "Mechanisms of I-Ks suppression in LQT1 mutants", AM J P-HEAR, 279(6), 2000, pp. H3003-H3011
65. Witchel, HJ; Hancox, JC
    Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    
    H.J. Witchel e J.C. Hancox, "Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current", CLIN EXP PH, 27(10), 2000, pp. 753-766
66. Fleischhauer, R; Davis, MW; Dzhura, I; Neely, A; Avery, L; Joho, RH
    Ultrafast inactivation causes inward rectification in a voltage-gated K+ channel from Caenorhabditis elegans
    JOURNAL OF NEUROSCIENCE
    
    R. Fleischhauer et al., "Ultrafast inactivation causes inward rectification in a voltage-gated K+ channel from Caenorhabditis elegans", J NEUROSC, 20(2), 2000, pp. 511-520
67. Emmi, A; Wenzel, HJ; Schwartzkroin, PA; Taglialatela, M; Castaldo, P; Bianchi, L; Nerbonne, J; Robertson, GA; Janigro, D
    Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes
    JOURNAL OF NEUROSCIENCE
    
    A. Emmi et al., "Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes", J NEUROSC, 20(10), 2000, pp. 3915-3925
68. Tie, H; Walker, BD; Valenzuela, SM; Breit, SN; Campbell, TJ
    The heart of psychotropic drug therapy
    LANCET
    
    H. Tie et al., "The heart of psychotropic drug therapy", LANCET, 355(9217), 2000, pp. 1825-1825
69. Taglialatela, M; Annunziato, L
    Evaluation of the cardiac safety of second-generation antihistamines
    ALLERGY
    
    M. Taglialatela e L. Annunziato, "Evaluation of the cardiac safety of second-generation antihistamines", ALLERGY, 55, 2000, pp. 22-30
70. Satoh, Y; Sugiyama, A; Tamura, K; Hashimoto, K
    Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic actionpotential
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    
    Y. Satoh et al., "Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic actionpotential", JPN CIRC J, 64(6), 2000, pp. 445-451
71. Drici, MD; Barhanin, J
    Cardiac K+ channels and drug-acquired long QT syndrome
    THERAPIE
    
    M.D. Drici e J. Barhanin, "Cardiac K+ channels and drug-acquired long QT syndrome", THERAPIE, 55(1), 2000, pp. 185-193
72. De Ponti, F; Poluzzi, E; Montanaro, N
    QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    F. De Ponti et al., "QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience", EUR J CL PH, 56(1), 2000, pp. 1-18
73. Sanchez-Chapula, JA; Sanguinetti, MC
    Altered gating of HERG potassium channels by cobalt and lanthanum
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    J.A. Sanchez-Chapula e M.C. Sanguinetti, "Altered gating of HERG potassium channels by cobalt and lanthanum", PFLUG ARCH, 440(2), 2000, pp. 264-274
74. Vereecke, J; Carmeliet, E
    The effect of external pH on the delayed rectifying K+ current in cardiac ventricular myocytes
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    J. Vereecke e E. Carmeliet, "The effect of external pH on the delayed rectifying K+ current in cardiac ventricular myocytes", PFLUG ARCH, 439(6), 2000, pp. 739-751
75. Schwartz, PJ; Priori, SG; Dumaine, R; Napolitano, C; Antzelevitch, C; Stramba-Badiale, M; Richard, TA; Berti, MR; Bloise, R
    A molecular link between the sudden infant death syndrome and the long-QT syndrome.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    P.J. Schwartz et al., "A molecular link between the sudden infant death syndrome and the long-QT syndrome.", N ENG J MED, 343(4), 2000, pp. 262-267
76. Kass, RS; Cabo, C
    Channel structure and drug-induced cardiac arrhythmias
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    R.S. Kass e C. Cabo, "Channel structure and drug-induced cardiac arrhythmias", P NAS US, 97(22), 2000, pp. 11683-11684
77. Mitcheson, JS; Chen, J; Lin, M; Culberson, C; Sanguinetti, MC
    A structural basis for drug-induced long QT syndrome
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J.S. Mitcheson et al., "A structural basis for drug-induced long QT syndrome", P NAS US, 97(22), 2000, pp. 12329-12333
78. Sesti, F; Abbott, GW; Wei, J; Murray, KT; Saksena, S; Schwartz, PJ; Priori, SG; Roden, DM; George, AL; Goldstein, SAN
    A common polymorphism associated with antibiotic-induced cardiac arrhythmia
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    F. Sesti et al., "A common polymorphism associated with antibiotic-induced cardiac arrhythmia", P NAS US, 97(19), 2000, pp. 10613-10618
79. Secondo, A; Taglialatela, M; Cataldi, M; Giorgio, G; Valore, M; Di Renzo, G; Annunziato, L
    Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH(3) cells
    MOLECULAR PHARMACOLOGY
    
    A. Secondo et al., "Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH(3) cells", MOLEC PHARM, 58(5), 2000, pp. 1115-1128
80. Heath, BM; Terrar, DA
    Protein kinase C enhances the rapidly activating delayed rectifier potassium current, I-Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes
    JOURNAL OF PHYSIOLOGY-LONDON
    
    B.M. Heath e D.A. Terrar, "Protein kinase C enhances the rapidly activating delayed rectifier potassium current, I-Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes", J PHYSL LON, 522(3), 2000, pp. 391-402
81. Kuryshev, YA; Brown, AM; Wang, L; Benedict, CR; Rampe, D
    Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    Y.A. Kuryshev et al., "Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels", J PHARM EXP, 295(2), 2000, pp. 614-620
82. Katayama, Y; Fujita, A; Ohe, T; Findlay, I; Kurachi, Y
    Inhibitory effects of vesnarinone on cloned cardiac delayed rectifier K+ channels expressed in a mammalian cell line
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    Y. Katayama et al., "Inhibitory effects of vesnarinone on cloned cardiac delayed rectifier K+ channels expressed in a mammalian cell line", J PHARM EXP, 294(1), 2000, pp. 339-346
83. Crumb, WJ
    Loratadine blockade of K+ channels in human heart: Comparison with terfenadine under physiological conditions
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    W.J. Crumb, "Loratadine blockade of K+ channels in human heart: Comparison with terfenadine under physiological conditions", J PHARM EXP, 292(1), 2000, pp. 261-264
84. Ficker, E; Dennis, AT; Obejero-Paz, CA; Castaldo, P; Taglialatela, M; Brown, AM
    Retention in the endoplasmic reticulum as a mechanism of dominant-negativecurrent suppression in human long QT syndrome
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    
    E. Ficker et al., "Retention in the endoplasmic reticulum as a mechanism of dominant-negativecurrent suppression in human long QT syndrome", J MOL CEL C, 32(12), 2000, pp. 2327-2337
85. Pond, AL; Scheve, BK; Benedict, AT; Petrecca, K; Van Wagoner, DR; Shrier, A; Nerbonne, JM
    Expression of distinct ERG proteins in rat, mouse, and human heart - Relation to functional I-Kr channels
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A.L. Pond et al., "Expression of distinct ERG proteins in rat, mouse, and human heart - Relation to functional I-Kr channels", J BIOL CHEM, 275(8), 2000, pp. 5997-6006
86. Kathofer, S; Zhang, W; Karle, C; Thomas, D; Schoels, W; Kiehn, J
    Functional coupling of human beta(3)-adrenoreceptors to the KvLQT1/MinK potassium channel
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S. Kathofer et al., "Functional coupling of human beta(3)-adrenoreceptors to the KvLQT1/MinK potassium channel", J BIOL CHEM, 275(35), 2000, pp. 26743-26747
87. Tamargo, J
    Drug-induced torsade de pointes: From molecular biology to bedside
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    J. Tamargo, "Drug-induced torsade de pointes: From molecular biology to bedside", JPN J PHARM, 83(1), 2000, pp. 1-19
88. Hayashi, K; Shimizu, M; Ino, H; Okeie, K; Yamaguchi, M; Yasuda, T; Fujino, N; Fujii, H; Fujita, S; Mabuchi, H
    Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG
    JAPANESE HEART JOURNAL
    
    K. Hayashi et al., "Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG", JPN HEART J, 41(3), 2000, pp. 399-404
89. Ulens, C; Tytgat, J
    Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation
    FEBS LETTERS
    
    C. Ulens e J. Tytgat, "Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation", FEBS LETTER, 474(1), 2000, pp. 111-115
90. Escande, D
    Pharmacogenetics of cardiac K+ channels
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D. Escande, "Pharmacogenetics of cardiac K+ channels", EUR J PHARM, 410(2-3), 2000, pp. 281-287
91. Bischoff, U; Schmidt, C; Netzer, R; Pongs, O
    Effects of fluoroquinolones on HERG currents
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    U. Bischoff et al., "Effects of fluoroquinolones on HERG currents", EUR J PHARM, 406(3), 2000, pp. 341-343
92. Kang, JS; Wang, L; Cai, F; Rampe, D
    High affinity blockade of the HERG cardiac K+ channel by the neuroleptic pimozide
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    J.S. Kang et al., "High affinity blockade of the HERG cardiac K+ channel by the neuroleptic pimozide", EUR J PHARM, 392(3), 2000, pp. 137-140
93. Larsen, LA; Svendsen, IH; Jensen, AM; Kanters, JK; Andersen, PS; Moller, M; Sorensen, SA; Sandoe, E; Jacobsen, JR; Vuust, J; Christiansen, M
    Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2
    CLINICAL GENETICS
    
    L.A. Larsen et al., "Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2", CLIN GENET, 57(2), 2000, pp. 125-130
94. Numaguchi, H; Mullins, FM; Johnson, JP; Johns, DC; Po, SS; Yang, ICH; Tomaselli, GF; Balser, JR
    Probing the interaction between inactivation gating and D-sotalol block ofHERG
    CIRCULATION RESEARCH
    
    H. Numaguchi et al., "Probing the interaction between inactivation gating and D-sotalol block ofHERG", CIRCUL RES, 87(11), 2000, pp. 1012-1018
95. Robertson, GA
    LQT2 - Amplitude reduction and loss of selectivity in the tail that wags the HERG channel
    CIRCULATION RESEARCH
    
    G.A. Robertson, "LQT2 - Amplitude reduction and loss of selectivity in the tail that wags the HERG channel", CIRCUL RES, 86(5), 2000, pp. 492-493
96. Shimizu, W; Antzelevitch, C
    Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of thelong-QT syndrome
    CIRCULATION
    
    W. Shimizu e C. Antzelevitch, "Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of thelong-QT syndrome", CIRCULATION, 102(6), 2000, pp. 706-712
97. Jiang, M; Cabo, C; Yao, JA; Boyden, PA; Tseng, GN
    Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle
    CARDIOVASCULAR RESEARCH
    
    M. Jiang et al., "Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle", CARDIO RES, 48(1), 2000, pp. 34-43
98. Tie, H; Walker, BD; Singleton, CB; Valenzuela, SM; Bursill, JA; Wyse, KR; Breit, SN; Campbell, TJ
    Inhibition of HERG potassium channels by the antimalarial agent halofantrine
    BRITISH JOURNAL OF PHARMACOLOGY
    
    H. Tie et al., "Inhibition of HERG potassium channels by the antimalarial agent halofantrine", BR J PHARM, 130(8), 2000, pp. 1967-1975
99. Zunkler, BJ; Kuhne, S; Rustenbeck, I; Ott, T
    Mechanism of terfenadine block of ATP-sensitive K+ channels
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B.J. Zunkler et al., "Mechanism of terfenadine block of ATP-sensitive K+ channels", BR J PHARM, 130(7), 2000, pp. 1571-1574
100. Jo, SH; Youm, JB; Lee, CO; Earm, YE; Ho, WK
     Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline
     BRITISH JOURNAL OF PHARMACOLOGY
     
     S.H. Jo et al., "Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline", BR J PHARM, 129(7), 2000, pp. 1474-1480